Evaluation of Patients for Radiotherapy for Prostate Adenocarcinoma
Prostate adenocarcinoma is the most common non-cutaneous malignancy among men in the United States, and the second leading cause of death. However, most prostate adenocarcinoma diagnoses are now diagnosed at early stages and are curable, or if they recur, are associated with such long survival times...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/85729 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Evaluation of Patients for Radiotherapy for Prostate Adenocarcinoma
- Radiotherapy in Prostate Cancer
- Production of Human Prostate Adenocarcinoma Tumoroids for Antitumor Testing
- Combination of Immunotherapy & Radiotherapy for the Treatment of Prostate Cancer
- Use of Radiobiological Modeling in Treatment Plan Evaluation and Optimization of Prostate Cancer Radiotherapy
- Stereotactic Body Radiotherapy for Pancreatic Adenocarcinoma: Set-Up Error Correction Using Internal Markers and It’s Association with the Patient’s Body Mass Index
- Lobe-Specific Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Mouse Model